These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8036894)

  • 1. [Anticancer immunoconjugates: current status and prospects].
    Zhen YS
    Yao Xue Xue Bao; 1994; 29(1):1-8. PubMed ID: 8036894
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of anticancer immunotoxins.
    Choudhary S; Mathew M; Verma RS
    Drug Discov Today; 2011 Jun; 16(11-12):495-503. PubMed ID: 21511052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific agents in development.
    Sznol M; Holmlund J
    Semin Oncol; 1997 Apr; 24(2):173-86. PubMed ID: 9129688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS; Pimm MV
    Cancer Chemother Biol Response Modif; 1988; 10():397-415. PubMed ID: 3079393
    [No Abstract]   [Full Text] [Related]  

  • 7. Technology evaluation: SGN-15, Seattle Genetics Inc.
    Smith S
    Curr Opin Mol Ther; 2001 Jun; 3(3):295-302. PubMed ID: 11497354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies and immunoconjugates for cancer treatment.
    Baldwin RW; Byers VS
    Cancer Chemother Biol Response Modif; 1987; 9():409-31. PubMed ID: 3079412
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of MG series monoclonal antibodies in the diagnosis and experimental targeting therapy of gastric cancer.
    Zhang X; Li S; Fan D
    Chin Med Sci J; 1991 Mar; 6(1):56-9. PubMed ID: 1786407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical studies with immunoconjugates.
    Pietersz GA; Smyth MJ; Kanellos J; Cunningham Z; McKenzie IF
    Targeted Diagn Ther; 1989; 2():73-97. PubMed ID: 2519551
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
    Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
    Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and development of antineoplastic agents from natural sources.
    Cragg GM; Newman DJ
    Cancer Invest; 1999; 17(2):153-63. PubMed ID: 10071600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineoplastic chemotherapy in 1980. Current status and prospects].
    Brun B; Rochant H
    Rev Prat; 1980 Jan; 30(5):209-18. PubMed ID: 6990462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of monoclonal antibody for cancer therapy].
    Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):157-62. PubMed ID: 8311485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in tumor-targeting anticancer drug conjugates.
    Jaracz S; Chen J; Kuznetsova LV; Ojima I
    Bioorg Med Chem; 2005 Sep; 13(17):5043-54. PubMed ID: 15955702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.
    Stan AC; Radu DL; Casares S; Bona CA; Brumeanu TD
    Cancer Res; 1999 Jan; 59(1):115-21. PubMed ID: 9892195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.